VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!
×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Mesothelioma
Angelica Welch
Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.
Mavis Nye BCAh
Lauren M. Green
After a shocking diagnosis, Heather Von St. James is on a mission to spread awareness about mesothelioma.
Silas Inman
Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.
Anita T. Shaffer
An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.
Charlotte Huff
Finding specialized care is worth the effort for patients with uncommon cancers.
Readers respond to past CURE articles on living with mesothelioma, hospice, beating bladder cancer, lung cancer, and response to CURE's 2007 Cancer Resource Guide.
Katy Human
Asbestos exposure is the main cause of mesothelioma, accounting for more than 80 percent of cases.